Medtronic’s Winning Formula in Spine

Medtronic reported FY 4Q24 orthopedic sales of $897.1 million, up 7% compared to the fiscal fourth quarter of 2023. For the company's fiscal 2024, it generated $3.38 billion in orthopedic sales, growing 6.8% compared to the prior year.

The company cited "outstanding" capital sales in the quarter, with double-digit revenue growth in Mazor...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us